TriSalus Life Sciences (TLSI) Misses Q3 EPS by 96c

TriSalus Life Sciences (NASDAQ: TLSI) reported Q3 EPS of ($0.96). Revenue for the quarter came in at $11.6 million.

For earnings history and earnings-related data on TriSalus Life Sciences (TLSI) click here.

You May Also Be Interested In

• Samsara Inc (IOT) call put ratio 4.5 calls to 1 put with a focus on September 4 weekly calls into quarter results
• Cliffwater Private Credit Fund Sees 16% Redemption Requests - Bloomberg
• John Wiley & Sons, Inc. (WLYB) Misses Q1 EPS by 2c ; Offers Guidance